Novo Nordisk Aktie
83,11
EUR
-17,51
EUR
-17,40
%
79,20
EUR
-20,10
EUR
-20,24
%
Novo Nordisk Aktie Analyse
12.06.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
11.06.19 | Novo Nordisk Outperform | Credit Suisse Group | |
11.06.19 | Novo Nordisk buy | UBS AG | |
11.06.19 | Novo Nordisk Equal weight | Barclays Capital | |
11.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.06.19 | Novo Nordisk Outperform | Bernstein Research | |
29.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
28.05.19 | Novo Nordisk Reduce | HSBC | |
Werbung
|
|||
28.05.19 | Novo Nordisk Reduce | HSBC | |
17.05.19 | Novo Nordisk Underweight | Barclays Capital | |
07.05.19 | Novo Nordisk buy | UBS AG | |
07.05.19 | Novo Nordisk Neutral | Oddo BHF | |
07.05.19 | Novo Nordisk Reduce | HSBC | |
06.05.19 | Novo Nordisk Underweight | Barclays Capital | |
06.05.19 | Novo Nordisk Outperform | Credit Suisse Group | |
06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.05.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
03.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.05.19 | Novo Nordisk buy | UBS AG | |
29.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
29.04.19 | Novo Nordisk Outperform | Credit Suisse Group | |
12.04.19 | Novo Nordisk Outperform | Bernstein Research | |
11.04.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
08.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.04.19 | Novo Nordisk buy | Deutsche Bank AG | |
20.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
18.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
18.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.03.19 | Novo Nordisk Outperform | Bernstein Research | |
05.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.03.19 | Novo Nordisk Reduce | HSBC | |
04.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.02.19 | Novo Nordisk Reduce | HSBC | |
05.02.19 | Novo Nordisk verkaufen | Barclays Capital | |
04.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
04.02.19 | Novo Nordisk buy | Deutsche Bank AG | |
04.02.19 | Novo Nordisk Neutral | Credit Suisse Group | |
01.02.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
01.02.19 | Novo Nordisk Hold | Jefferies & Company Inc. | |
01.02.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
01.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
28.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
21.01.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.01.19 | Novo Nordisk buy | Deutsche Bank AG | |
03.01.19 | Novo Nordisk Outperform | Bernstein Research | |
02.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
14.12.18 | Novo Nordisk Equal-Weight | Morgan Stanley | |
11.12.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
10.12.18 | Novo Nordisk buy | Deutsche Bank AG |